Why the study?
Should single-pill combinations be used as first-line treatment for all patients with arterial hypertension?
Should single-pill combinations be used as first-line treatment for all patients with arterial hypertension?
The paper discusses the strong recommendation in the 2018 ESC/ESH guidelines for using single-pill combinations as first-line therapy for hypertension.
May inform first-line single-pill combinations per guidelines; leaves open universal applicability without higher-level evidence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: